在ARA-C输液反应的成年患者中成功消毒
Yasemin Akgul Balaban1, Mustafa Ilker Inan1, Ali Selcuk1
1Division of Immunology and Allergic Diseases, Gulhane Training and Research Hospital, Ankara, Turkiye.
概括
在患有血液性恶性瘤的患者中,可以发生cytarabine (ARA-C) 输液反应. 为患有B细胞急性淋巴细胞白血病的成年患者开发了一种成功的脱敏化方案,该患者经历了这些反应.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 临床药房 临床药房
背景情况:
- 赛塔拉宾 (ARA-C) 是用于血液恶性瘤的关键抗代谢剂化疗剂.
- 输液反应是ARA-C治疗的重要副作用,通常模仿过敏反应.
- 对输液反应的有效管理对于继续癌症治疗至关重要.
相关概念视频
01:20Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
02:06Allergic Reactions
27.3K
Overview
27.3K
01:30Hypersensitivities
626
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
626